Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/23/2003CA2480814A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003CA2480764A1 Novel polymorphs and pseudopolymorphs of resedronate sodium
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480425A1 Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480403A1 Drug-complex microparticles and methods of making/using same
10/23/2003CA2480365A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003CA2480332A1 Drinking tea for treating dermatitis
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/23/2003CA2470016A1 Antibiotic product, use and formulation thereof
10/23/2003CA2469736A1 Diphenhydramine tannate solid dose compositions and methods of use
10/23/2003CA2469338A1 Diphenhydramine tannate liquid and semi-solid compositions and methods of use
10/23/2003CA2453256A1 Diphenhydramine tannate compositions and methods of use
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
10/22/2003EP1354588A1 Method for delivering benzindene prostaglandind by inhalation
10/22/2003EP1354587A1 Medicinal compositions for oral use
10/22/2003EP1354586A1 The use of hydroxpyridone-derivatives in wound healing
10/22/2003EP1354584A1 Preventives for arthritis
10/22/2003EP1354583A2 Aerosols containing beclomethasone nanoparticle dispersions
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1354581A1 Porous substance and process for producing the same
10/22/2003EP1354518A1 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and use thereof
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1353968A1 Linear block polymer
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353933A1 Method for purification of lactose
10/22/2003EP1353932A1 Compositions containing a ruthenium(iii) complex and a heterocycle
10/22/2003EP1353714A1 A drug delivery device
10/22/2003EP1353701A2 Methods and compositions for enhanced delivery of bioactive molecules
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353685A2 Controlled release pharmaceutical systems
10/22/2003EP1353679A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/22/2003EP1353668A1 Methods of administering epothilone analogs for the treatment of cancer
10/22/2003EP1353667A1 Parenteral formulations containing epothilone analogs
10/22/2003EP1353663A1 Fenofibrate tablets
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003EP1353654A2 Devices and methods for heat-pulse assisted thermal applications of active substances
10/22/2003EP1353653A1 Chewing gums and related products that provide breath freshening characteristics
10/22/2003EP1353652A2 Pharmaceutical tablet comprising paroxetine mesylate
10/22/2003EP1353651A2 Extended release pharmaceutical compositions containing beta-lactam antibiotics
10/22/2003EP1353650A2 Process for preparing non-hygroscopic sodium valproate composition
10/22/2003EP1353649A2 Personal medication dispensing card
10/22/2003EP1353648A2 Microparticles of biodegradable polymer encapsulating a biologically active substance
10/22/2003EP1353647A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
10/22/2003EP1353645A1 Method for the production and use of a cream containing vitamin-a.
10/22/2003EP1353629A2 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields
10/22/2003EP1353624A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
10/22/2003EP1227735B1 Chewing gum compositions
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1164996B1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/22/2003EP1150661B1 Topical sprays comprising a film forming composition
10/22/2003EP1148923B1 Removable filter for slurry hydrocarbon synthesis process
10/22/2003EP1140105B1 Controlled release galantamine composition
10/22/2003EP1140031B1 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
10/22/2003EP1077677B1 Process for the manufacture of a biologically active composition
10/22/2003EP1071404B1 Softgel-compatible composition containing retinol
10/22/2003EP1043977B1 Oral pharmaceutical pulsed release dosage form
10/22/2003EP1041984B1 Pharmaceutical composition for oral administration
10/22/2003EP0975334B1 Biodegradable microparticles for the sustained delivery of therapeutic drugs
10/22/2003EP0954440B1 Removable protective film for plaster systems, in particular self-adhesive plaster systems, containing active substances
10/22/2003EP0948321B1 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance
10/22/2003EP0948319B1 Encapsulated cells producing antibodies
10/22/2003EP0934746B1 Substance in the form of an aqueous extract of vegetal raw material for treating oncological diseases, and method for producing the same
10/22/2003EP0929293B1 Liposomes containing a cisplatin compound
10/22/2003EP0877600B1 Preservative systems for pharmaceutical compositions containing cyclodextrins
10/22/2003EP0862424B1 Pharmaceutical compositions comprising flurbiprofen
10/22/2003EP0831963B1 Microfabricated porous membranes with bulk support
10/22/2003EP0773781B1 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
10/22/2003EP0729369B1 Method and apparatus for delivering oxygen
10/22/2003CN1450923A Method and compositions for administering taxanes orally to human patients
10/22/2003CN1450914A Preparation of aqueous clear solution dosage forms with bile acids
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1450904A Use of ribose to prevent cramping and soreness in muscles
10/22/2003CN1450902A Medicinal composition composed of metformin and glyburide
10/22/2003CN1450899A Bile secretion promoting composition
10/22/2003CN1450896A Use of indole derivatives for intracular pressure for reducing
10/22/2003CN1450895A Pharmaceutical compositions of estrogenic agents
10/22/2003CN1450893A Method for treatment of sepsis
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450890A Novel compositions of minoxidil
10/22/2003CN1450883A Transdermal delivery system for alkaloids of aconitum species
10/22/2003CN1450882A Transdermal administration of huperzine
10/22/2003CN1449862A Multiple emulsions
10/22/2003CN1449840A System and method for remotely medicine infusion and analyte monitoring
10/22/2003CN1449832A Horse SARS-resisting serum
10/22/2003CN1449825A Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
10/22/2003CN1449823A Use of ulinastatin in treating SARS and medicinal composition thereof
10/22/2003CN1449822A New use of gene recombinant human lysozyme in pharmacy for curing coronal virus of SARS
10/22/2003CN1449821A Stable recombination human alpha interferon liquid preparation and productive process thereof
10/22/2003CN1449819A Weishengli oral liquid medicine and preparation process thereof
10/22/2003CN1449811A Qinbei granules preparation for curing cough in children and preparation method thereof
10/22/2003CN1449798A Compound belladonna bismuth-magnesium tablet and preparation process thereof
10/22/2003CN1449796A Capsule containing ginkgo leaf extract
10/22/2003CN1449794A Radix bupleuri soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449792A Medicine composition with synergrstic action and preparation process and use thereof
10/22/2003CN1449790A Cool and throat-moistening aerosol
10/22/2003CN1449785A Massage ointment for treating neck, shoulder, waist and leg pain, and extremity numbness
10/22/2003CN1449769A Soft capsule of Chinese Forest Frog's Oviduct Fat and preparation method thereof
1 ... 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 ... 2991